GB8332653D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB8332653D0
GB8332653D0 GB838332653A GB8332653A GB8332653D0 GB 8332653 D0 GB8332653 D0 GB 8332653D0 GB 838332653 A GB838332653 A GB 838332653A GB 8332653 A GB8332653 A GB 8332653A GB 8332653 D0 GB8332653 D0 GB 8332653D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB838332653A
Other versions
GB2131691A (en
GB2131691B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8332653D0 publication Critical patent/GB8332653D0/en
Publication of GB2131691A publication Critical patent/GB2131691A/en
Application granted granted Critical
Publication of GB2131691B publication Critical patent/GB2131691B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
GB08332653A 1982-12-10 1983-12-07 Pharmaceutical composition comprising hydrogenated ergotalkaloid and heparin Expired GB2131691B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3245695 1982-12-10

Publications (3)

Publication Number Publication Date
GB8332653D0 true GB8332653D0 (en) 1984-01-11
GB2131691A GB2131691A (en) 1984-06-27
GB2131691B GB2131691B (en) 1986-12-03

Family

ID=6180290

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08332653A Expired GB2131691B (en) 1982-12-10 1983-12-07 Pharmaceutical composition comprising hydrogenated ergotalkaloid and heparin

Country Status (25)

Country Link
JP (1) JPH0672101B2 (en)
AT (1) AT382514B (en)
AU (1) AU570658B2 (en)
BE (1) BE898356A (en)
CA (1) CA1224416A (en)
CH (1) CH656533A5 (en)
CY (1) CY1509A (en)
DD (1) DD215469B3 (en)
DK (1) DK162475C (en)
FR (1) FR2537435B1 (en)
GB (1) GB2131691B (en)
GR (1) GR79745B (en)
HK (1) HK23290A (en)
HU (1) HU190513B (en)
IE (1) IE56366B1 (en)
IL (1) IL70406A (en)
IT (1) IT1172368B (en)
LU (1) LU85127A1 (en)
NL (1) NL8304221A (en)
NZ (1) NZ206523A (en)
PH (1) PH23451A (en)
PT (1) PT77803B (en)
SE (1) SE468973B (en)
SG (1) SG53989G (en)
ZA (1) ZA839200B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432661A1 (en) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger CARCINOM THERAPEUTIC
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1245761B (en) * 1991-01-30 1994-10-14 Alfa Wassermann Spa PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE441142B (en) * 1975-12-04 1985-09-16 Sandoz Ag PROCEDURE FOR PREPARING A THERAPEUTIC PREPARATION WITH ANTITHROMOBOTIC PROPERTIES
DE2554533C3 (en) * 1975-12-04 1984-08-30 Sandoz-Patent-Gmbh, 7850 Loerrach Use of dihydroergotamine and heparin
DE2809618A1 (en) * 1978-03-06 1979-09-20 Sandoz Ag NEW THERAPEUTIC PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
DE3020895A1 (en) * 1979-06-12 1980-12-18 Sandoz Ag ERGOPEPTIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE ERGOPEPTIN DERIVATIVES
DE2945636A1 (en) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach STABLE SOLUTIONS OF HYDRATED ERGOTAL CALOIDS OR YOUR SALTS AND HEPARIN OR ITS SALTS AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
SE468973B (en) 1993-04-26
HU190513B (en) 1986-09-29
IE56366B1 (en) 1991-07-03
DD215469B3 (en) 1988-03-09
PT77803A (en) 1984-01-01
NL8304221A (en) 1984-07-02
ATA428483A (en) 1986-08-15
HK23290A (en) 1990-04-06
AT382514B (en) 1987-03-10
HUT34124A (en) 1985-02-28
LU85127A1 (en) 1984-10-22
JPH0672101B2 (en) 1994-09-14
NZ206523A (en) 1987-04-30
SG53989G (en) 1989-12-29
IT1172368B (en) 1987-06-18
SE8306792L (en) 1984-06-11
GR79745B (en) 1984-10-31
FR2537435A1 (en) 1984-06-15
PH23451A (en) 1989-08-07
CA1224416A (en) 1987-07-21
CY1509A (en) 1990-08-03
GB2131691A (en) 1984-06-27
GB2131691B (en) 1986-12-03
IT8349456A0 (en) 1983-12-07
IL70406A0 (en) 1984-03-30
FR2537435B1 (en) 1987-03-20
SE8306792D0 (en) 1983-12-08
BE898356A (en) 1984-06-04
DK162475C (en) 1992-05-11
IL70406A (en) 1988-08-31
DK162475B (en) 1991-11-04
ZA839200B (en) 1985-07-31
CH656533A5 (en) 1986-07-15
IE832896L (en) 1984-06-10
DK565783A (en) 1984-06-11
PT77803B (en) 1986-04-17
AU570658B2 (en) 1988-03-24
JPS59116222A (en) 1984-07-05
DK565783D0 (en) 1983-12-08
AU2222183A (en) 1984-06-14
DD215469A5 (en) 1984-11-14

Similar Documents

Publication Publication Date Title
GB8326565D0 (en) Pharmaceutical compositions
GB8327612D0 (en) Pharmaceutical compositions
EP0138029A3 (en) Pharmaceutical composition
ZA834074B (en) Pharmaceutical composition
ZA833781B (en) Pharmaceutical compositions
EP0093551A3 (en) Pharmaceutical composition
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
PT77323B (en) Pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
GB8328896D0 (en) Pharmaceutical composition
DE3377696D1 (en) Pharmaceutical compositions
US4594359B1 (en) Pharmaceutical compositions
GB2114001B (en) Nasel pharmaceutical compositions
GB8305028D0 (en) Pharmaceutical compositions
GB8332653D0 (en) Pharmaceutical composition
GB8314736D0 (en) Pharmaceutical compositions
GB8330810D0 (en) Pharmaceutical compositions
GB8308414D0 (en) Pharmaceutical composition
GB8331068D0 (en) Pharmaceutical compositions
GB8314540D0 (en) Pharmaceutical composition
GB8329391D0 (en) Pharmaceutical compositions
GB8312121D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19951207